Hakan Ekmekci

Hakan Ekmekci

Auto-generated profile, based on publicly available information

Hakan Ekmekci

Department of Biochemistry, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
TDTaskin Duman
Taskin Duman
DUDerya Uluduz
Derya Uluduz
IMIpek Midi
Ipek Midi
HBHesna Bektas
Hesna Bektas
YKYuksel Kablan
Yuksel Kablan
NUNevzat Uzuner
Nevzat Uzuner

18 June 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AAAyşe Ağbaş
Ayşe Ağbaş
NCNur Canpolat
Nur Canpolat
SCSalim Caliskan
Salim Caliskan
AYAlev Yılmaz
Alev Yılmaz
HEHakan Ekmekçi
Hakan Ekmekçi
RSRukshana Shroff
Rukshana Shroff
Randomized trials in adults have shown reduced all-cause and cardiovascular mortality on hemodiafiltration (HDF) compared to high-flux hemodialysis (HD), but the mechanisms leading to improved outcomes are not clear. We studied biomarkers of inflammation, oxidative stress, anti-oxidant capacity and endothelial dysfunction in 22 children (13 female, age 8–15 years). All children received HD for at least 3 months, and were then switched to HDF, keeping all dialysis related parameters and dialysis time constant. All the biomarkers of inflammation (ß2-microglobulin, IL-6, IL-10, high sensitive C-reactive protein [hsCRP]), oxidative stress (nitrotyrosine, advanced glycation end-products [AGEs], oxidized low density lipoprotein [ox-LDL] and anti-oxidant capacity) and endothelial dysfunction (asymmetric dimethyl arginine [ADMA], symmetric dimethyl arginine [SDMA]), were comparable between incident and prevalent patients on HD, suggesting that even a short dialysis vintage of 3 months on HD increases inflammation and endothelial stress. After 3 months of HDF therapy there was a significant reduction in ß2-microglobulin (p<0.001), hCRP, ADMA, SDMA, AGEs, ox-LDL (p<0.01 for all) and an increase in total antioxidant capacity (p<0.001) compared to HD. All children were maintained on the same dialyser, dialysis water quality, dialysis time and blood flow speeds suggesting that improved clearances on HDF led to an improved biomarker profile. Even in children with residual renal function there was a significant reduction in ß2 microglobulin, hsCRP, SDMA, ox-LDL and AGEs on HDF compared to HD. Children with a lower blood flow had higher inflammatory status (higher IL-6/IL-10 ratio; p = 0.04, r = -0.43). Children who achieved a higher convective volume (≥median 12.8L/m2) had lower ox-LDL (p = 0.02). In conclusion, we have shown that a significant improvement in inflammation, antioxidant capacity and endothelial risk profile is achieved even within a short time (3 months) on HDF compared to HD treatment. Trial Registration: ClinicalTrials.gov: NCT02063776.

1 April 2006 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
HEHakan Ekmekci
Hakan Ekmekci
OEOzlem B. Ekmekci
Ozlem B. Ekmekci
Obesity is a major risk factor for morbidity and mortality from cardiovascular causes. Adiponectin has been identified recently as one of the adipocytokines with important metabolic effects. It can suppress atherogenesis by inhibiting the adherence of monocytes, reducing their phagocytic activity, and suppressing the accumulation of modified lipoproteins in the vascular wall. In addition, as adiponectin decrease endothelial damage and stimulates production of NO from vascular endothelial cells, hypoadiponectinemia may be partially contribute to thrombus formation.

1 June 2006 in Clinica Chimica Acta
Verified
Journal Article
Closed access
ÖEÖzlem Balcı Ekmekçi
Özlem Balcı Ekmekçi
HEHakan Ekmekçi
Hakan Ekmekçi

1 December 2002 in Journal of Thrombosis and Thrombolysis
Verified
Journal Article
Closed access
PDF file
HEHakan Ekmekci
Hakan Ekmekci
HSHuseyin Sonmez
Huseyin Sonmez
OEOzlem B. Ekmekci
Ozlem B. Ekmekci
ZOZeynep Ozturk
Zeynep Ozturk
NDNergiz Domanic
Nergiz Domanic
EKEmine Kokoglu
Emine Kokoglu

20 December 2014 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
ÖEÖzlem Balcı Ekmekçi
Özlem Balcı Ekmekçi
HEHakan Ekmekçi
Hakan Ekmekçi
ZGZeynep Banu Güngör
Zeynep Banu Güngör
ATAbdullah Tüten
Abdullah Tüten
MTM. Sait Toprak
M. Sait Toprak
HSHüseyin Sönmez
Hüseyin Sönmez